Latest Breaking News On - அயூப் காட்டக் - Page 1 : comparemela.com
Roundup: India clears POC use of Cue Health s COVID-19 test, NZ-based Titanium Solutions buys Irish dental software developer and more briefs
mobihealthnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mobihealthnews.com Daily Mail and Mail on Sunday newspapers.
Cue Health Receives Regulatory Approval in India for its Molecular, Point-of-Care COVID-19 Test
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Photo: Courtesy of Cue Health
Cue Health, a rapid diagnostics startup with a connected testing device platform, has closed a massive $235 million private financing round.
Investments were made by new backers Perceptive Advisors, MSD Capital and Koch Strategic Platforms, as well as by existing investors including Johnson & Johnson Innovation, Decheng Capital, CAVU Ventures, ACME Capital, and others.
WHAT IT DOES
The San Diego-based startup’s lead product is the Cue Health Monitoring System, a molecular testing device designed for use in care settings, schools, homes and other places. The system consists of a single-use testing swab, a disposable cartridge and a portable reader. It can deliver results within 20 minutes.
Cue Health Announces Completion of $235 Million Private Financing to Accelerate Growth
Investment Includes Participation from Perceptive Advisors, MSD Capital, Koch Strategic Platforms, and Johnson & Johnson Innovation - JJDC, Inc. (JJDC)
News provided by
Share this article
Share this article
SAN DIEGO, May 13, 2021 /PRNewswire/ Cue Health Inc. ( Cue Health or Cue ), a health technology company, today announced the closing of a $235 million private financing round. The investment includes participation from new investors Perceptive Advisors, MSD Capital, and Koch Strategic Platforms, a subsidiary of Koch Industries, existing investors Johnson & Johnson Innovation – JJDC, Inc. (JJDC), Decheng Capital, CAVU Ventures, ACME Capital, and others. The capital will be used to accelerate Cue s growth as it pioneers a digital transformation of healthcare, beginning with diagnostics.
Cue Health Inc., a San Diego, CA-based health technology company, closed a $235m financing round.
Backers included Perceptive Advisors, MSD Capital, and Koch Strategic Platforms, a subsidiary of Koch Industries, existing investors Johnson & Johnson Innovation – JJDC, Inc. (JJDC), Decheng Capital, Cavu Ventures, ACME Capital, and others.
The company intends to use the funds to accelerate growth.
Led by Ayub Khattak, co-founder and CEO, Cue is a health technology company that enables people to manage their health through real-time, actionable and connected health data. The company offers individuals and healthcare providers access to lab-quality diagnostic testing at home, at work, or at the point-of-care, all in a handly device.
vimarsana © 2020. All Rights Reserved.